中文 | English
Return
Total: 76 , 1/8
Show Home Prev Next End page: GO
Author:( Haifeng SONG)

1.Advances in the research of anti-CD20 therapeutic monoclonal antibodies.

Chenglian DENG ; Jia ZOU ; Haifeng SONG

Acta Pharmaceutica Sinica 2013;48(10):1515-20

2.Study of laparoscopic versus open appendectomy

Xueliao SONG ; Yukuang YAN ; Haifeng PENG

Chinese Journal of Primary Medicine and Pharmacy 2008;15(z1):4-5

3.Study of the clinical effect in the treatment of the mixed hemorrhoids

Xueliao SONG ; Yukuang YAN ; Haifeng PENG

Chinese Journal of Primary Medicine and Pharmacy 2008;15(z1):28-29

4.Application of LC-MS/MS to quantitative bioanalysis of monoclonal antibodies in biological matrices

Yijue WU ; Li LI ; Haifeng SONG

Military Medical Sciences 2016;40(8):686-690

5.Advance in the study of targeting delivery system for siRNA mediated by aptamers.

Xiaolin WANG ; Qingqing WANG ; Haifeng SONG

Acta Pharmaceutica Sinica 2012;47(7):850-5

6.Comparison of Two Quantitative Assays for Determination of Rh-anti-CD20 zumab and Their Application to Pharmacokinetic Study

Chenglian DENG ; Jia ZOU ; Lun OU ; Lihou DONG ; Haifeng SONG

Chinese Journal of Analytical Chemistry 2014;(3):337-342

7.Diagnosis of plasma cell mastitis with multi-slice spiral CT

Song WANG ; Haifeng MA ; Xifu WANG ; Bing XU

Journal of Integrative Medicine 2005;3(3):199-202

8.Analysis on drugs application in elderly patients with renal insufficiency

Ningzhou GAO ; Jie SHEN ; Zhongjuan SONG ; Haifeng ZHOU ; Yunxuan ZHANG

Chinese Journal of Geriatrics 2016;35(3):274-277

9.Expressions of integrin in human keloid-derived mesenchymal stem cells

Haifeng SONG ; Wenting WANG ; Tao LIU ; Yanguo ZHANG

Chinese Journal of Dermatology 2015;48(7):459-462

10.Recent progress for HBV infection model in vitro and in vivo

Guili XU ; Xin GAO ; Zhengzhu LIU ; Yuanfang GONG ; Haifeng SONG

Chinese Journal of Comparative Medicine 2016;26(9):93-98

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 76 , 1/8 Show Home Prev Next End page: GO